Whitehawk Therapeutics, Inc.

WHWK

Whitehawk Therapeutics, Inc.

WHWK

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-04-16Shares Purchased (TTM):0Shares Sold (TTM):355,487

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:34,139,934Shares Outstanding:69,236,945Institutional Ownership Pct.:49.31%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	85	35	38	38	145	228	29	31	41	54	63	69
Short Term Investments	105	88	108	125	32	3	19	32	37	34	46	51
Accounts Receivable Net Current	-	-	0	0	0	0	6	7	6	5	5	6
Inventory Net	-	-	0	0	0	0	5	5	6	6	6	4
Prepaid Expense And Other Assets Current	2	3	3	2	1	2	3	3	2	3	4	4
Assets Current	192	126	149	165	179	233	61	77	93	103	125	133
Property Plant And Equipment Net	0	0	0	0	0	0	7	6	6	6	5	4
Operating Lease Right Of Use Asset	-	-	0	0	0	0	1	1	1	1	1	1
Other Assets Noncurrent	2	2	2	2	2	1	1	2	2	2	2	2
Assets	194	127	151	167	181	234	70	86	102	111	132	140
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	2	1	2	3	4	2	1	2	3	6	3
Accrued Liabilities Current	10	9	14	8	5	9	15	14	14	11	14	12
Operating Lease Liability Current	-	-	0	0	0	0	0	0	0	0	0	0
Liabilities Current	11	11	15	10	9	12	17	16	22	20	26	21
Operating Lease Liability Noncurrent	-	-	0	0	0	0	1	1	1	1	1	1
Other Liabilities Noncurrent	-	-	0	0	0	0	0	0	-	-	0	-
Liabilities	11	11	15	10	9	12	18	17	23	21	27	21
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	575	492	489	487	484	481	385	383	381	378	374	371
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-392	-375	-353	-330	-312	-260	-333	-314	-302	-287	-269	-253
Stockholders Equity	183	116	136	157	172	222	52	69	79	90	105	118
Liabilities And Stockholders Equity	194	127	151	167	181	234	70	86	102	111	132	140
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	57	47	47	47	47	47	25	25	25	25	25	25
Shares Outstanding	57	47	47	47	47	47	25	25	25	25	25	25

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	19.80%	5.58%	-5.84%	-	-	-	-	-	-	-	-	-
2025	3.05%	17.68%	18.90%	4.94%	12.79%	40.12%	11.43%	27.14%	28.57%	-10.00%	2.31%	21.03%
2024	-2.17%	-20.65%	-14.13%	34.07%	42.96%	48.89%	10.38%	51.42%	48.11%	-17.80%	-9.95%	2.62%
2023	-	-	-	7.72%	-11.03%	-21.88%	7.31%	-56.56%	-64.09%	-1.39%	-1.85%	-16.67%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	17.38	11.36	10.26	16.76	20.41	18.95	3.59	4.89	4.20	5.16	4.72	6.48
Quick Ratio	17.16	11.13	10.03	16.51	20.24	18.83	3.11	4.37	3.81	4.69	4.33	6.10
Working Capital	181.35M	114.49M	134.49M	155.19M	169.92M	220.34M	44.21M	61.50M	70.86M	82.70M	98.19M	112.37M
Leverage & Debt
Debt to Equity	0.06	0.10	0.11	0.06	0.05	0.06	0.34	0.24	0.29	0.23	0.26	0.18
Interest Coverage TTM	-	-	-	-	-2,692.87	-657.96	-438.04	-313.85	-305.88	-323.03	-311.40	-303.00
Debt Ratio	0.06	0.09	0.10	0.06	0.05	0.05	0.25	0.20	0.22	0.19	0.21	0.15
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.06	0.11	0.15	0.16	0.26	0.22	0.19	0.17	0.15	0.14
Days Sales Outstanding TTM	-	-	-	-	-	-	80.01	89.23	73.53	80.36	55.08	62.61
Receivables Turnover TTM	-	-	-	-	-	-	4.56	4.09	4.96	4.54	6.63	5.83
Per Share Metrics
Diluted EPS TTM	-0.96	-1.67	-0.33	-0.23	-0.15	0.69	-2.36	-2.28	-2.42	-2.55	-2.44	-2.35
Free Cash Flow Per Share TTM	-0.84	-1.56	-1.58	-1.39	-1.40	-1.34	-2.26	-2.09	-1.98	-2.27	-2.36	-2.40
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	88.72%	88.36%	87.39%	87.18%	87.70%	88.47%	90.95%
Operating Profit Margin TTM	-	-	-1,601.12%	-754.05%	-473.83%	-227.41%	-259.62%	-264.15%	-296.67%	-313.00%	-295.36%	-299.68%
Net Profit Margin TTM	-	-	-288.26%	-108.58%	-48.24%	99.42%	-245.13%	-246.06%	-274.77%	-288.72%	-270.04%	-272.67%
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-100.00%	-72.50%	-42.62%	-9.33%	16.51%	6.69%	7.80%	10.57%	26.97%	60.06%	111.62%
Net Income Growth (1Y)	666.28%	-519.37%	-67.66%	-74.68%	-84.08%	-140.12%	-3.15%	-2.72%	6.27%	11.23%	8.68%	1.31%
EPS Growth (1Y)	538.67%	-340.11%	-85.88%	-90.11%	-93.78%	-127.31%	-3.55%	-3.06%	5.76%	10.75%	-9.11%	-20.04%
Valuation Metrics
P/E TTM	-4.76	-2.06	-7.27	-8.42	-12.40	2.56	-1.34	-0.90	-0.60	-0.92	-0.83	-2.06
P/B TTM	2.08	2.06	1.10	0.84	0.75	0.32	1.63	0.81	0.50	0.70	0.52	1.10
P/S TTM	-	-	20.96	9.14	5.98	2.54	3.28	2.22	1.66	2.65	2.23	5.61
Market Cap	379.62M	238.87M	149.77M	131.49M	129.19M	70.56M	85.28M	55.71M	39.43M	63.13M	54.37M	130.42M
Enterprise Value	294.38M	204.08M	112.20M	93.56M	-15.75M	-157.01M	56.61M	25.17M	-1.70M	9.35M	-8.51M	61.62M
Calculated Values
Free Cash Flow TTM	-69.35M	-107.78M	-97.99M	-95.99M	-96.49M	-53.23M	-61.20M	-56.43M	-53.60M	-61.35M	-63.64M	-64.56M
Net Debt	-85.23M	-34.79M	-37.57M	-37.93M	-144.94M	-227.57M	-28.67M	-30.54M	-41.14M	-53.78M	-62.89M	-68.80M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-16Sale

Owner: Giacobello, Scott M.

Title: CHIEF FINANCIAL OFFICER

Shares: 141,600

Price/Share: $4.13

Value: $584,808.00

Shares Owned: 295,224

Relationship: Officer

Ownership: Direct

2026-04-14Sale

Owner: Ball, Bryan

Title: See remarks

Shares: 92,460

Price/Share: $3.64

Value: $336,554.40

Shares Owned: 397,106

Relationship: Officer

Ownership: Direct

2026-04-10Sale

Owner: Ball, Bryan

Title: See remarks

Shares: 6,596

Price/Share: $3.43

Value: $22,624.28

Shares Owned: 515,955

Relationship: Officer

Ownership: Direct

2026-04-09Sale

Owner: Lennon, David James

Title: CHIEF EXECUTIVE OFFICER

Shares: 14,500

Price/Share: $3.38

Value: $49,010.00

Shares Owned: 518,622

Relationship: Director,Officer

Ownership: Direct

2026-04-08Sale

Owner: Lennon, David James

Title: CHIEF EXECUTIVE OFFICER

Shares: 63,945

Price/Share: $3.40

Value: $217,413.00

Shares Owned: 533,122

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-16	Giacobello, Scott M.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	141,600	4.13	$584,808.00	295,224	4
2026-04-14	Ball, Bryan	Officer	See remarks	Direct	Sale	92,460	3.64	$336,554.40	397,106	4
2026-04-10	Ball, Bryan	Officer	See remarks	Direct	Sale	6,596	3.43	$22,624.28	515,955	4
2026-04-09	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	14,500	3.38	$49,010.00	518,622	4
2026-04-08	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	63,945	3.40	$217,413.00	533,122	4
2026-04-02	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	26,858	3.48	$93,465.84	793,549	4
2026-03-02	Ball, Bryan	Officer	See remarks	Direct	Sale	1,834	3.31	$6,070.54	206,019	4
2026-03-02	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	5,100	3.31	$16,881.00	44,579	4
2026-03-02	Giacobello, Scott M.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,594	3.31	$8,586.14	28,100	4
2025-03-03	Ball, Bryan	Officer	See remarks	Direct	Sale	2,147	2.35	$5,045.45	102,853	4
2025-03-03	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	5,690	2.35	$13,371.50	33,429	4
2025-03-03	Giacobello, Scott M.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,806	2.35	$6,594.10	23,944	4
2024-10-03	Lennon, David James	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	9,689	1.94	$18,796.66	22,869	4
2024-09-03	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	40,000	1.71	$68,400.00	1,171,543	4
2024-08-05	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	5,652	1.34	$7,573.68	1,211,543	4
2024-07-02	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	8,652	1.34	$11,593.68	1,251,543	4
2024-06-04	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	20,225	1.77	$35,798.25	1,291,543	4
2024-05-01	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	40,000	1.93	$77,200.00	1,331,543	4
2024-04-02	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	22,228	2.23	$49,568.44	1,371,543	4
2024-03-04	Desai, Neil	Director,Officer	EXECUTIVE CHAIRMAN	Indirect	Sale	14,964	2.10	$31,424.40	1,411,543	4
2024-02-01	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	42,000	1.74	$73,080.00	1,453,543	4
2024-01-02	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	42,000	2.06	$86,520.00	1,495,543	4
2023-12-06	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	7,037	4.82	$33,918.34	1,537,543	4
2023-12-05	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	15,740	5.02	$79,014.80	1,544,580	4
2023-11-02	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	31,662	4.46	$141,212.52	1,579,543	4
2023-10-03	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	16,431	4.10	$67,367.10	1,621,543	4
2023-09-06	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	7,111	5.29	$37,617.19	1,663,543	4
2023-08-02	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	19,290	5.20	$100,308.00	1,705,543	4
2023-07-06	Desai, Neil	Director,Officer	Executive Chairman	Indirect	Sale	15,829	6.27	$99,247.83	1,747,543	4
2023-06-06	Desai, Neil	Director,Officer,TenPercentOwner	Executive Chairman	Indirect	Sale	7,260	8.19	$59,459.40	1,789,543	4
2023-06-05	Desai, Neil	Director,Officer,TenPercentOwner	Executive Chairman	Indirect	Sale	17,315	8.11	$140,424.65	1,796,803	4
2023-05-04	Desai, Neil	Director,Officer,TenPercentOwner	Executive Chairman	Indirect	Sale	2,305	7.57	$17,448.85	1,831,543	4
2023-05-03	Desai, Neil	Director,Officer,TenPercentOwner	Executive Chairman	Indirect	Sale	7,695	7.68	$59,097.60	1,833,848	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

49.31%

Inst. Shares: 34,139,934

Shares Outstanding: 69,236,945

2025-12-31

53.25%

Inst. Shares: 32,952,867

Shares Outstanding: 61,886,765

2025-09-30

41.62%

Inst. Shares: 28,805,190

Shares Outstanding: 69,204,899

2025-06-30

42.61%

Inst. Shares: 29,433,054

Shares Outstanding: 69,083,127

2025-03-31

80.15%

Inst. Shares: 31,773,392

Shares Outstanding: 39,640,826

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	34,139,934	69,236,945	49.31%
2025-12-31	32,952,867	61,886,765	53.25%
2025-09-30	28,805,190	69,204,899	41.62%
2025-06-30	29,433,054	69,083,127	42.61%
2025-03-31	31,773,392	39,640,826	80.15%
2024-12-31	14,962,965	27,029,942	55.36%
2024-09-30	11,951,563	27,041,327	44.20%
2024-06-30	11,380,955	27,010,013	42.14%
2024-03-31	12,476,628	26,980,698	46.24%
2023-12-31	12,302,234	26,917,967	45.70%
2023-09-30	13,656,354	26,946,683	50.68%
2023-06-30	13,442,850	26,879,089	50.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Whitehawk Therapeutics, Inc. (WHWK) — SEC Financial Statements & Analysis

Whitehawk Therapeutics, Inc. (WHWK) is a pharmaceutical preparations company, incorporated in DE. Whitehawk Therapeutics, Inc. trades on Nasdaq as: WHWK. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Whitehawk Therapeutics, Inc. reported a -100.00% year-over-year revenue growth, a Gross Profit Margin of 88.72% (TTM), a Debt-to-Equity ratio of 0.06x, a Price-to-Sales (P/S) ratio of 20.96x (TTM), a Price-to-Book (P/B) ratio of 2.08x (TTM), at a market cap of $379.62M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Gross Profit Margin TTM: 88.72%
Debt To Equity: 0.06x
P/S TTM: 20.96x
P/B TTM: 2.08x
Market Cap: $379.62M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Whitehawk Therapeutics, Inc. in?

Whitehawk Therapeutics, Inc. (WHWK) operates in the Pharmaceutical Preparations industry.

What is WHWK's market cap?

Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $379.62M as of 2026-06-30.

What exchange does WHWK trade on?

Whitehawk Therapeutics, Inc. (WHWK) trades on the Nasdaq.

Where is Whitehawk Therapeutics, Inc. incorporated?

Whitehawk Therapeutics, Inc. is incorporated in DE.